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Abstract
Background: Intravenous leiomyomas are a rare variant of uterine leiomyoma. Although histologically benign,
these tumors are associated with a poor prognosis due to propensity for metastasis, high recurrence rate, difficulty
of obtaining complete resection, and frequent extension into and along major veins.
Case presentation: We describe a 43-year-old patient initially presenting with lower abdominal pain. Clinical
examination revealed a large right pelvic mass that was shown by computed tomography (CT) to surround the
right external iliac vein, right common iliac vein and distal inferior vena cava. The patient had a history of total
abdominal hysterectomy with bilateral ovarian cystectomies for uterine leiomyoma approximately 3 years prior
to her presentation. Her past surgical history also included removal of an ovarian endometriosis cyst and right
hydrosalpinx. The patient underwent an exploratory laparotomy. Operative findings included complete occlusion of
the right iliac vessels and distal vena cava by a large tumor that filled the pelvis and extended to the level of the
right kidney. The mass was resected en bloc with the involved veins and synthetic vascular grafts were placed. This
highly technical procedure was complicated by hemorrhage requiring a total of 32 units of red blood cells and
2.0 L of plasma. Pathologic examination confirmed intravenous leiomyoma. On Immunohistochemical staining, the
tumor cells were positive for CD32, CD34, Vimentin and smooth muscle actin. Eight months after this procedure,
the patient again presented with an abdominal mass. She was diagnosed with a pelvic recurrence and noted to
have intravascular extension into the left iliac vein and inferior vena cava. For this tumor she underwent radiation
treatment with three-dimensional conformal radiation therapy (total dose 4500 cGy). The tumor gradually
decreased in size during follow-up and became undetectable by CT.
Conclusions: Surgical excision is the mainstay of treatment of intravenous leiomyoma. Radiation therapy may be
an effective alternative in patients with unresectable disease or poor surgical candidates.
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Background
Leiomyomas are the most common type of uterine neo-
plasm; however, there are several less common variants of
leiomyomas. Angioleiomyoma or intravenous leiomyoma
(IVL) are a rare variant that originates from mesenchymal
tissue. IVL was first described in 1896 by Birch-Hirschfeld.
Although it is a benign tumor, IVL has malignant biologic
behavior making its management difficult. Because IVL is
often diagnosed after it has metastasized to other locations,
it generally has a poor prognosis [1]. The tumor can
progress to involve the iliac veins, the inferior vena cava
(IVC), and even the right atrium [2].
Here we present a rare case of uterine IVL with two
recurrences. Our patient was treated with multiple opera-
tions, including an extensive resection with grafting of the
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iliac veins, as well as radiation therapy in order to obtain
tumor control. We are the first authors to present the use
of radiation therapy for this indication.
Case presentation
The patient is a 43-year-old woman who presented with
a large pelvic mass and was admitted to Shandong
Cancer Hospital and Institute in June 2006. Her only
complaint was lower abdominal pain. Pertinent past
medical and surgical history include: benign hypertension
for 2 years, prior cesarean delivery, prior hysterectomy,
and inferior vena cava filter placement approximately
three years prior for history of venous thrombus.
The patient reported undergoing a total hysterectomy
and bilateral ovarian cystectomies for uterine fibroids
3 years prior to this presentation at a local hospital. Patho-
logic review of this specimen shows uterine IVL based on
the Immunohistochemical staining profile and <5 mitotic
figures per 10 high-power fields. Additionally, in April
2006, three months prior to her current presentation, the
patient was diagnosed with a pelvic mass with complaints
of lower abdominal pain and underwent a resection of an
ovarian cyst and right salpingectomy. The histopathological
assessment of the specimen was an ovarian endometriosis
cyst and right hydrosalpinx.
At the time of presentation, gynecologic bimanual exam
revealed a palpable mass in the right pelvis, measuring
approximately 10 cm × 10 cm× 8 cm. It was firm and
non-tender to palpation. The mass appeared to invade the
rectovaginal space and extend beyond the pelvis into the
abdomen.
Contrast-enhanced computed tomography (Fig. 1) of
the abdomen and pelvis demonstrated a large soft tissue
mass with partial cystic degeneration, measuring 25 cm×
13.5 cm × 7 cm. The mass was noted to be surrounding
the right external and internal iliac veins, right common
iliac vein and distal IVC. It was in close proximity to the
right common iliac artery and abdominal aorta up to the
level of the right kidney. Doppler ultrasound showed that
tumors blood supply was likely originating from the iliac
artery.
Based on the physical exam and radiological findings,
combined with the medical history, a preliminary diagno-
sis of intravascular leiomyoma was made with extension
into the right iliac vein and IVC. The recommended treat-
ment was surgical resection. The patient was counseled
that surgery would include en bloc resection of the mass
with vascular grafting of the distal IVC and common iliac
vessels as needed.
Surgery was performed under general anesthesia on
July 5, 2006. Upon abdominal entry, two large masses
were noted in the right retroperitoneum. One mass was
abdominal and measured approximately 20 cm× l8 cm×
10 cm. This mass encased the distal IVC,the right com-
mon iliac vein and right external and internal iliac veins.
It was closely adherent to the right internal iliac artery.
The other mass measured approximately 10 cm× 10 cm×
8 cm and was adherent to the bladder wall, pelvic floor,
and right iliac veins. Upon further exploration, the two
masses were connected as a single tumor in a dumb-bell
shape. The right external and internal iliac veins, right
common iliac vein and IVC were completely occluded by
the tumor. The right internal iliac and common iliac arter-
ies were dissected off the tumor. The right internal iliac
vein was ligated distal to the tumor. The tumor was dis-
sected off the pelvic sidewall. Next the distal IVC and right
external iliac vein were ligated. Finally, the left common
iliac vein was ligated to free all venous attachments from
the tumor and obtain a surgical margin. The tumor had a
predominant blood supply from a single pedicle which
was divided and the tumor removed en bloc. The en bloc
resection included the distal IVC with proximal left com-
mon iliac vein, entire right common iliac vein, and prox-
imal portion of the right internal and external iliac veins.
An 8 mm expanded polytetrafluoroethylene vascular graft
(by Bard Medical) was placed to reconnect the distal IVC
to the left common iliac vein with 4-0 Prolene suture to
restore venous return to the left lower extremity and pel-
vis. Given that the patient had developed significant
Fig. 1 June 16, 2006. A large soft tissue mass with dumb-bell shape and partial cystic degeneration, measuring 25 cm × 13.5 cm × 7 cm. The mass
was enlarged since the prior operation 2 months previously. It surrounded the right external and internal iliac veins, right common iliac vein and
distal inferior vena cava. It was close in proximity to the right common and internal iliac arteries and aorta up to the level of the right kidney
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collateral flow with no right extremity edema or venous
stasis, the right iliac veins were not reconstructed. Re-
moval of the tumor was challenging with an estimated in-
traoperative blood loss of 5.0 L. In total the patient
was transfused 32 units of packed red blood cells and
2.0 L of plasma. Postoperatively the patient was
closely observed for distal pulses, evidence of edema,
and lower extremity compartment syndrome.
Postoperative pathology confirmed this mass to be an
intravenous leiomyoma arising from the right internal
iliac vein (Fig. 2). Immunohistochemistry shows the endo-
thelial cells to be positive for CD31, CD34, Vimentin and
smooth muscle actin. The cells stain negative for cytokera-
tin with low expression of p53 protein and high expres-
sion of progesterone receptor and Bcl-2.
The patient was managed postoperatively on anticoa-
gulation and given nutritional support with intravenous
nutrition until able to tolerate oral intake. She ultimately
recovered from the operation and was discharged in a
stable condition on postoperative day 20.
Eight months following her surgical resection, the pa-
tient represented complaining of an enlarging abdomen
and frequent urination. She was readmitted to hospital in
March 2007. Clinical examination revealed a mass
measuring approximately 6 cm × 6 cm in the left pelvis.
CT examination revealed a soft tissue mass close to the
previously resected tumor involving the right internal iliac
vessels, measuring 3.5 cm × 4 cm× 4 cm. A separate mass
was also seen posterior to the bladder on the left, measur-
ing 3 cm× 5 cm× 6.5 cm (Fig. 3). This was felt to repre-
sent a pelvic recurrence of IVL. The patient was deemed
to not be an operative candidate given deconditioning
from the prior surgery. Three-dimensional conformal ra-
diation therapy was performed for tumor control. External
beam radiation was planned using an ADAC Treatment
Planning System, delivered with 15MV X-ray from a
Varian 21EX (Palo Alto, CA) and designed from CT scans.
External irradiation was 2.0 Gy daily fraction, 4 fractions
per week, the total dose of radiation was 4500 cGy.
Following radiation therapy, the patient was followed
closely. A subsequent CT scan in October 2010 demon-
strated a pelvic mass on the right of the bladder and
rectum. It was again felt to be surrounding the distal
IVC and iliac blood vessels. The largest cross-sectional
area was 4.0 cm × 2.0 cm (Fig. 4). This lesion was not
further treated, but followed with serial imaging and
Fig. 2 Pathologic diagnosis. The tissue was rich in blood vessels, and tumor cells were arranged around the blood vessels (hematoxylin and eosin, 100×)
Fig. 3 March 26, 2007. There was a soft tissue mass close to the site of the prior tumor near the right internal iliac vessels, measuring 3.5 cm ×
4.0 cm × 4.0 cm. Additionally, a left sided mass behind the bladder, measured 3.0 cm × 5.0 cm × 6.5 cm
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resolved. At most recent follow-up 8 years after radi-
ation therapy in July 2015 the patient remains without
evidence of recurrence on physical examination and CT
images (Fig. 5).
Discussion
IVL is a rare benign neoplasm arising from the vascular
smooth muscle [1]. It presents as a painful mass in ~60 %
of cases [3]. IVL is the benign hyperplasia of smooth
muscle cells, as is seen in uterine fibroids, but it has pro-
pensity to grow and metastasize like a malignant tumor. It
has been reported to involve the IVC, right atrium, and
lungs and may be potentially life-threatening [2]. A patient
presenting following a hysterectomy for leiomyoma with a
solid abdominopelvic mass on clinical examination or im-
aging, should prompt providers to consider a recurrence
of IVL [4, 5].
In complex cases of IVL, whether a tumor can be
completely resected depends primarily on the extent of
involvement of associated vessels [6]. Forced detachment
can easily damage vessels, especially veins with thin,
fragile walls, and result in severe hemorrhage. An in-
complete resection can result in the residual tumor
cells on the vascular surface recurring in the future.
The controversy in these types of cases includes
whether to resect and reconstruct the iliac veins, as
well as how this should be done. As a result of the
development of advanced vascular surgical techniques
and vascular grafts, we were able to completely resect
the tumor en bloc with the involved vessels, and
implant vascular grafts [7, 8].
It was necessary to determine the size and shape of
the mass as well as the scope and extent of the involved
adjacent organs, especially in relationship to the iliac veins
and IVC. This evaluation can be performed using contrast-
enhanced CT, magnetic resonance imaging, nuclear
magnetic resonance angiography, and digital subtraction
angiography [5, 9]. In the presented case, the complex in-
volvement of the mass with critical veins made complete
resection of the tumor unlikely, without damaging the as-
sociated veins. Therefore, the decision was made to remove
the tumor en bloc with the affected veins using vascular
grafting. By performing en bloc resection with reconstruc-
tion of the iliac vessels, there was an improved chance for
optimal cytoreduction, and therefore reduced risk of recur-
rence with associated improvement in survival [7].
Undertaking such an extensive operation carries
significant risks for the patients and surgeons. Careful
preparations preoperatively, correct judgment intraopera-
tively, and close postoperative observation is essential.
Success also requires close cooperation among multiple
teams ranging from vascular surgeons to general
surgeons to anesthesiologists and intensive care unit
(ICU) physicians.
The mainstay of treatment for IVL is surgical removal,
including cases of recurrence and metastasis. Prognosis
of IVL depends on whether the tumor is completely
resected [10]. As a result, patients not desiring future
fertility should be advised to undergo total hysterectomy.
However, up to 30 % of patients can develop recurrence
and metastasis after initial tumor resection [10]. There-
fore, whether or not the tumor is completely resected,
routine postoperative follow-up is necessary for prompt
Fig. 4 Oct 7, 2010. A pelvic mass to the right of the bladder and rectum measuring 4 .0 cm × 2.0 cm
Fig. 5 July 3, 2015. No signs of recurrence were detected at follow up
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diagnosis and treatment of any recurrences [11]. Some
studies suggest that IVL is hormone-dependent making
anti-hormonal therapy a possible treatment strategy [12].
Anti-estrogens such as GnRH agonists like Leuprorelin
Acetate have been used for treatment of IVL [13]. But the
role of anti-estrogens therapy for IVL in general remains
unclear [11, 14].
Determining the best curative treatment option for
a patient who is not suitable for surgery is challenging. In
the present case there were concerns surrounding the
use of hormonal therapy in a patient with prior
venous thromboembolism. Given that the patient was
deemed not to be a surgical candidate due to decon-
ditioning and concerns surrounding use of hormonal
therapy, she was counseled by her team and opted
for radiation therapy. Ultimately, this strategy was
shown to be successful with effective control of the
tumor, and its gradual reduction to no visible tumor
on her most recent CT (Fig. 5).
It is well-documented that radiation therapy is a
commonly used means of treating malignant tumors.
There are also case reports of selectively using radi-
ation treatments for benign tumors, especially those
with biologic activity mimicking malignancy [15, 16].
While malignant tumors usually display immediate
response to radiation therapy, our patient displayed a
delayed response to radiation therapy with appreciable
decrease in the size of the tumor beginning 3 months
after completion of treatment. No residual tumor was
seen on imagining 6 months following treatment. We
suspect that the overall slow response rate to radi-
ation observed was a result of the relatively slow
growth rate of IVL compared to malignancy. Given
that radiation relies on DNA damage leading to the
inability to replicate, this relatively slow growing
tumor took longer to respond to radiation than would
be expected for a malignancy. When radiation therapy
is applied to benign tumors, it can be used at lower
doses. This offers the advantage of fewer side effects,
which may be more acceptable to patients, especially
in those who are not surgical candidates.
Conclusion
For IVL, radical surgical excision remains the mainstay
of treatment. In cases where dissection of the tumor off
involved vessels appears to be challenging or not feas-
ible, consideration should be given to vascular resection
en bloc with graft placement in order to obtain a
complete tumor resection. In the event of a recurrence
or tumor in a patient deemed a poor surgical candidate,
radiation therapy is feasible and effective alternative to
surgical or medical management for prevention or treat-
ment of recurrence.
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